You are using an outdated browser. We suggest you update your browser for a better experience.
Click here
for update.
Close this notification.
Skip to main content
Skip to search
CCO
Cancer Care Ontario
Ontario Renal Network
EN
FR
Recently Viewed
Cancer Care Ontario
Open Navigation
Close Navigation
Home
Types of Cancer
Cancer Treatments
Get Checked for Cancer
Find Services
Indigenous
Ontario Cancer Plan
COVID-19
Drug Formulary
Drugs
Regimens
Funding & Reimbursement
Side Effects
Drug Safety & Information
Pre-Printed Orders
What’s New
Guidelines & Advice
Browse Guidelines
Types of Cancer
Modality of Care
Cancer Continuum
Most Popular Documents
What’s New in Guidelines & Advice
About Guidelines
Toolkits
Education & Events
Managing Symptoms
COVID-19 Resources
Pathway Maps
Browse Pathway Maps
Bladder Cancer
Breast Cancer
Cervical Cancer
Colorectal Cancer
Endometrial Cancer
Esophageal Cancer
Lung Cancer
Oropharyngeal Cancer
Ovarian Cancer
Prostate Cancer
Skin Cancer
Soft Tissue Sarcoma
Thyroid Cancer
Cervical Lymphadenopathy in Adults Pathway Map
Hepatocellular Cancer Pathway Map
Data & Research
Accessing Data
View Data
Submitting Data
Our Research
Funding Opportunities
Open Search
Close Search
Open Navigation
Close Navigation
All
Drug Formulary
Guidelines and Advice
Data
Cancer Care Ontario
General Cancer Info
Pathway Maps
Sort by
Most Relevant
Letter (A-Z)
Most Recent
You are here
Search
You may filter this list by entering a keyword to the right
Refine Your Results
8 Results
Drug
dexrazoxane
Other Name(s): Zinecard®
Quick Link(s):
Drug Monograph
,
Patient Info Sheet
Dec 2020
Regimen
DCRB
Cancer Type:
Sarcoma,
Soft Tissue,
Skin,
Melanoma
Show More
Show more tags
, Show Less
Show fewer tags
Intent:
Palliative
Drugs Used:
dacarbazine
...
Show more tags
, Collapse
Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2020
Regimen
DCTN
Cancer Type:
Gynecologic,
Gestational Trophoblastic Disease
Show More
Show more tags
, Show Less
Show fewer tags
Intent:
Curative
Drugs Used:
DACTINomycin
...
Show more tags
, Collapse
Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2020
Regimen
DOXO(W)
Cancer Type:
Gynecologic,
Endometrial
Show More
Show more tags
, Show Less
Show fewer tags
Intent:
Palliative
Drugs Used:
DOXOrubicin
...
Show more tags
, Collapse
Show fewer tags
Quick Link(s):
Regimen Monograph
May 2020
Regimen
DHAP+RITU
Cancer Type:
Hematologic,
Lymphoma - Non-Hodgkin's High Grade,
Lymphoma - Non-Hodgkin's Intermediate Grade
Show More
Show more tags
, Show Less
Show fewer tags
Intent:
Curative
Funding:
New Drug Funding Program
Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Aggressive Histology Lymphoma
ODB - General Benefit
dexamethasone
New Drug Funding Program
Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Aggressive Histology Lymphoma
Show More
Show more tags
, Show Less
Show fewer tags
Drugs Used:
dexamethasone
,
riTUXimab
,
CISplatin
,
cytarabine
,
riTUXimab (subcut)
...
Show more tags
, Collapse
Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2020
Regimen
DCRBDOXO
Cancer Type:
Sarcoma,
Soft Tissue
Show More
Show more tags
, Show Less
Show fewer tags
Intent:
Adjuvant, Curative, Palliative
Drugs Used:
dacarbazine
,
DOXOrubicin
...
Show more tags
, Collapse
Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2020
Regimen
DEXASELI
Cancer Type:
Hematologic,
Multiple Myeloma
Show More
Show more tags
, Show Less
Show fewer tags
Intent:
Palliative
Funding:
ODB - General Benefit
dexamethasone
Show More
Show more tags
, Show Less
Show fewer tags
Drugs Used:
selinexor
(Unfunded)
,
dexamethasone
...
Show more tags
, Collapse
Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2020
Cancer facts
Diabetes leads to increased risk of dying among First Nations women with breast cancer in Ontario
Nov 2020